Bioventix PLC
BVXP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 6.78 | -1.43 | 10.79 | -1.05 |
| FCF Yield | 2.45% | 2.22% | 1.77% | 1.93% |
| EV / EBITDA | 27.98 | 32.51 | 41.15 | 42.60 |
| Quality | ||||
| ROIC | 33.06% | 33.23% | 34.40% | 34.55% |
| Gross Margin | 92.59% | 87.84% | 92.39% | 93.21% |
| Cash Conversion Ratio | 0.92 | 0.98 | 1.00 | 1.09 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.95% | 10.14% | 10.46% | 11.68% |
| Free Cash Flow Growth | -4.45% | -8.87% | -8.01% | 20.03% |
| Safety | ||||
| Net Debt / EBITDA | -1.03 | -1.04 | -1.11 | -1.06 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.69 | 1.48 | 0.86 | 0.77 |
| Cash Conversion Cycle | 204.30 | -43.31 | 156.59 | -142.92 |